The Blood Center — FDA Facility Profile

FEI 2374536

The Blood Center is an FDA-inspected facility (FEI 2374536) located in Hammond, LA, US. RegDataLab tracks 9 FDA inspections at this facility.

Reviewing The Blood Center as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check The Blood Center yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Aug 16, 2024: No Action Indicated (NAI)
Inspections on record
9 (4 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
84, latest Jul 10, 2025

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 16, 2024No Action Indicated (NAI)No citations listed
Jun 17, 2022Voluntary Action Indicated (VAI)Concurrent documentation (21 CFR 606.160(a)(1))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Biological product deviation report (21 CFR 606.171)
Thorough investigations (21 CFR 606.100(c))
Apr 17, 2019Voluntary Action Indicated (VAI)Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Jun 29, 2017Voluntary Action Indicated (VAI)Concurrent documentation (21 CFR 606.160(a)(1))
Biological product deviation report (21 CFR 606.171)
Jul 16, 2015Voluntary Action Indicated (VAI)No citations listed
Dec 11, 2014No Action Indicated (NAI)No citations listed
May 18, 2012No Action Indicated (NAI)No citations listed
Aug 25, 2011No Action Indicated (NAI)No citations listed
Sep 3, 2010No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 84 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jul 10, 2025Class IIB-0202-2026Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced, incorrectly labeled as irradiated, were distributed.
Apr 15, 2025Class IIB-0131-2026Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count…
Apr 11, 2025Class IIB-0146-2026Platelets, Pathogen Reduced
Platelets, Pathogen Reduced, for which platelet yield did not meet specifications, were distributed.
Oct 24, 2022Class IIB-0331-2023Red Blood Cells and 1 more product
Blood products, collected from a donor previously deferred for testing reactive for syphilis, were distributed.
Oct 4, 2022Class IIB-0250-2023Platelets, Pathogen Reduced and 1 more product
Blood products, collected from donors previously deferred for testing reactive for syphilis and who were not properly tested for re-entry…
Aug 12, 2022Class IIB-0203-2023Platelets, Pathogen Reduced and 5 more products
Blood Products, collected from a donor who initially tested reactive for syphilis but did not have confirmatory testing performed according…
Nov 16, 2021Class IIB-0178-2022Platelets, Pathogen Reduced
Blood product, collected from a donor who previously tested positive for Hepatitis B core antigen (anti-HBc) on two separate occasions, was…
Nov 5, 2019Class IIIB-0336-2020Apheresis Red Blood Cells, Leukocytes Reduced
Misbranded Apheresis Red Blood Cells, Leukoreduced, were distributed.
Sep 27, 2019Class IIB-0092-2020Red Blood Cells and 1 more product
Red Blood Cell products, for which Chagas Disease testing was not performed, were distributed.
Apr 8, 2019Class IIIB-0687-2019Red Blood Cells, Leukocytes Reduced, Irradiated
Blood product, which was irradiated labeled with an incorrect expiration date, was distributed.

Facility details

Company
The Blood Center
Location
Hammond, LA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.